Search results
FDA panel backs Guardant’s blood test for colon cancer
MedTech Dive via Yahoo Finance· 12 hours agoGuardant expects the FDA to decide whether to approve Shield later this year. This story was...
Genetic Mutation Underlying Finland’s ‘Salty Liquorice’ Cats Identified
Forbes· 18 hours agoOh, this is fun: a collaboration of scientists at the University of Helsinki and at the company...
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at...
WKBN 27 Youngstown· 1 day agoOn May 10, 2024, Cure Genetics announced the safety and efficacy data of their CAR-NKT product, CGC729, for patients with relapsed and refractory metastatic renal cell carcinoma ...
Exact Sciences stock drops as Guardant Health test supported by FDA panel By Investing.com
Investing.com· 9 hours agoExact Sciences (NASDAQ:EXAS) stock dropped Friday after news that the Molecular and Clinical ...
The Zacks Analyst Blog Highlights Apple, Mastercard, Amgen, Utah Medical Products and Bridger...
Zacks via Yahoo Finance· 10 hours agoAs such, the stock warrants a cautious stance. (You can read the full research report on Mastercard...
I have a family history of Alzheimer’s disease. I wanted to understand my own risk | CNN
CNN.com· 5 days agoEditor’s note: CNN Chief Medical Correspondent Dr. Sanjay Gupta is a practicing neurosurgeon and...
Russell Investments Group Ltd. Reduces Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
ETF DAILY NEWS· 7 days agoRussell Investments Group Ltd. trimmed its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 25.9% during the 4th quarter, according to the company in its ...
Amalgamated Bank Buys 692 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
ETF DAILY NEWS· 7 days agoAmalgamated Bank lifted its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with ...
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer
WTNH-TV New Haven· 4 days agoSOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share ...